| Literature DB >> 30548286 |
Kang Ding1, Yan-Yan Tan1, Yang Ding2, Yuan Fang2, Xu Yang1, Jian Fang1, Da-Chao Xu1, Hui Zhang3, Wei Lu2, Meng Li2, Shi-Cai Huang2, Meng-Ling Cai2, Yan Song2, Yi-Jiang Ding1, Su-Min Zhang1.
Abstract
In this article, we aim to examine the novel effects of β-sitosterol on murine experimental colitis. β-Sitosterol significantly reduces the weight loss, colon length, and alleviated microscopic appearances of colitis induced by dextran sulfate sodium. This compound also decreases the levels of TNF-α, IL-6, and IL-1β in intestinal tissue of mice with experimental colitis in a concentration-dependent manner. β-Sitosterol treatment to intestinal epithelial cells significantly increases expression of antimicrobial peptides and reduces survival of intracellular Salmonella typhimurium. These results showed the multiple effects of β-sitosterol against pathogenic bacteria for a novel approach to the treatment of colonic inflammation.Entities:
Keywords: Crohn’s disease (CD); antimicrobial peptides (AMPs); dextran sulfate sodium (DSS); β-sitosterol, ulcerative colitis (UC)
Year: 2018 PMID: 30548286 DOI: 10.1002/jcb.27853
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429